Cargando…
Monoclonal Antibodies for Early Treatment of COVID-19 in a World of Evolving SARS-CoV-2 Mutations and Variants
Monoclonal antibodies targeting the receptor binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 spike protein are important outpatient treatment options in coronavirus disease 2019 to mitigate progression of disease and prevent hospitalization. The impact of different RBD mutati...
Autores principales: | Pogue, Jason M, Lauring, Adam S, Gandhi, Tejal N, Marshall, Vincent D, Eschenauer, Gregory A, Nagel, Jerod L, Baang, Ji Hoon, Zhou, Shiwei, Valesano, Andrew L, Petty, Lindsay A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194619/ https://www.ncbi.nlm.nih.gov/pubmed/34291118 http://dx.doi.org/10.1093/ofid/ofab268 |
Ejemplares similares
-
1035. Implementation of an Antimicrobial Stewardship Program-Led, Multifactorial Pneumonia Diagnosis and Treatment Bundle
por: Cua, Jefferson L, et al.
Publicado: (2019) -
A Multi-Faceted Antimicrobial Stewardship Program (ASP) Intervention Using Clinical Pharmacists Reduces Antibiotic Use and Hospital-Acquired Clostridium difficile Infection (HA-CDI)
por: Boyd, Anthony M, et al.
Publicado: (2017) -
Tocilizumab for treatment of mechanically ventilated patients with COVID-19
por: Somers, Emily C, et al.
Publicado: (2020) -
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
por: Somers, Emily C, et al.
Publicado: (2020) -
Successful Treatment of Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Immunodeficiency With Extended Nirmatrelvir/Ritonavir: Case Series
por: Breeden, Madison, et al.
Publicado: (2023)